Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease
- PMID: 16544172
- DOI: 10.1007/s10157-005-0404-5
Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease
Abstract
Remarkable regional differences in the annual incidence of endstage renal disease (ESRD) was found within Japan, which has a relatively homogeneous ethnic composition. In addition, there existed no regional difference in the incidence of ESRD due to polycystic kidney disease, the major genetic disorder of the kidneys. These findings suggest that the presence of factors other than genetic disposition contribute to the differences. On the other hand, there were similar regional variations in the incidences of ESRD between two causes of ESRD: chronic glomerulonephritis and diabetic nephropathy. Because it is unlikely that the regional distribution of underlying disease incidence and the disease-specific progression rate would be similar for two different causes, this observation suggests that factors governing the progression rate, which operate commonly for all causes of ESRD but differ among regions, may play an important role in generating the regional differences. Finally, we examined regional differences in the amounts of inhibitors of the renin-angiotensin system used, especially angiotensin-converting enzyme (ACE) inhibitors, in our search for an explanation of the regional differences in ESRD dynamics. Among antihypertensive agents examined, only ACE inhibitors were negatively correlated with the annual incidence of ESRD. The renal protective effects of ACE inhibitors have been established by results with animal models of progressive nephropathy and by large-scale clinical trials. Our epidemiological results for Japan as a whole show the same protective effects still more convincingly from a different approach. It is not completely clear yet at present, however, how regional variations in the incidence of ESRD are generated. If we could identify in future the factors that contribute to the regional differences, strategies for the treatment of renal disease will become available from different angles. Thus, much effort will be encouraged for the further analysis of regional differences in ESRD dynamics.
Similar articles
-
Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan.Kidney Int. 2003 Oct;64(4):1445-9. doi: 10.1046/j.1523-1755.2003.00221.x. Kidney Int. 2003. PMID: 12969164
-
Different regional dynamics of end-stage renal disease in Japan by different causes.Nephrology (Carlton). 2005 Aug;10(4):400-4. doi: 10.1111/j.1440-1797.2005.00404.x. Nephrology (Carlton). 2005. PMID: 16109089
-
Regional differences in end-stage renal disease and amount of protein intake in Japan.J Ren Nutr. 2007 Mar;17(2):118-25. doi: 10.1053/j.jrn.2006.12.010. J Ren Nutr. 2007. PMID: 17321951
-
Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II).J Renin Angiotensin Aldosterone Syst. 2005 Sep;6(2):55-68. doi: 10.3317/jraas.2005.011. J Renin Angiotensin Aldosterone Syst. 2005. PMID: 16470484 Review.
-
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].Presse Med. 2002 Nov 9;31(36):1714-20. Presse Med. 2002. PMID: 12467154 Review. French.
Cited by
-
Japanese subpopulation analysis of the RENAAL, the landmark trial, is welcomed by our society.Clin Exp Nephrol. 2006 Sep;10(3):226-7. doi: 10.1007/s10157-006-0430-y. Clin Exp Nephrol. 2006. PMID: 17009082 No abstract available.
-
Environmental factors influencing the survival of chronic dialysis patients.Clin Exp Nephrol. 2011 Jun;15(3):405-409. doi: 10.1007/s10157-010-0400-2. Epub 2011 Jan 20. Clin Exp Nephrol. 2011. PMID: 21249416
-
Predicted prevalence in Japan of chronic kidney disease (CKD).Clin Exp Nephrol. 2007 Jun;11(2):188-189. doi: 10.1007/s10157-007-0474-7. Epub 2007 Jun 28. Clin Exp Nephrol. 2007. PMID: 17593522 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous